Hostname: page-component-f554764f5-68cz6 Total loading time: 0 Render date: 2025-04-09T03:54:40.821Z Has data issue: false hasContentIssue false

Smallpox Vaccines for Monkeypox: Is Emergency Vaccination Imminent?

Published online by Cambridge University Press:  02 April 2025

Syed Mukareem Ali
Affiliation:
Dow University of Health Sciences, Karachi, Pakistan
Khabab Abbasher Hussien Mohamed Ahmed*
Affiliation:
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
Areeba Ahsan
Affiliation:
Foundation University, School of Health Sciences, Islamabad, Pakistan
Ghassan E. Mustafa Ahmed
Affiliation:
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
Irtebaat Fatima
Affiliation:
Dow University of Health Sciences, Karachi, Pakistan
Samiuddin Tariq Ahmed
Affiliation:
Dow University of Health Sciences, Karachi, Pakistan
Faizan Niaz
Affiliation:
Dow University of Health Sciences, Karachi, Pakistan
Irfan Ullah
Affiliation:
Kabir Medical College, Gandhara University, Peshawar, Pakistan
Abdul Waris
Affiliation:
Kabir Medical College, Gandhara University, Peshawar, Pakistan
*
Corresponding author: Khabab Abbasher Hussien Mohamed Ahmed; Email: [email protected]

Abstract

Monkeypox virus (MPXV) is a contagious disease that has been endemic in central and west Africa since 1970, characterized by symptoms such as fever, headache, and skin rash. While there is no approved treatment for MPXV infections, vaccination has proven effective in limiting its transmission, and previous smallpox vaccinations may also provide protection against monkeypox. However, the dependence of monkeypox on animal hosts makes eradication more complicated than with smallpox. Research should focus on assessing the safety of the vaccines, their duration of immunity, and their efficacy against the prevalent strains of monkeypox. The virus’s accelerated rate of mutation poses additional challenges, as does the fact that it can be transmitted through animals, making eradication more complex than with smallpox. A comprehensive global immunization strategy is needed to address these complexities and draw on lessons learned from past eradication efforts.

Type
Commentary
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

World Health Organization: WHO, World Health Organization: WHO. Mpox. Published August 26, 2024. Accessed https://www.who.int/news-room/fact-sheets/detail/monkeypoxGoogle Scholar
Ilic, I, Macuzic, IZ, Ilic, M. Global outbreak of human monkeypox in 2022: update of epidemiology. Trop Med Infect Dis. 2022;7(10):264. doi:10.3390/tropicalmed7100264CrossRefGoogle ScholarPubMed
Wenham, C, Eccleston-Turner, M. Monkeypox as a PHEIC: implications for global health governance. The Lancet. 2022;400(10369):21692171. doi:10.1016/s0140-6736(22)01437-4CrossRefGoogle ScholarPubMed
Administration USF and D. FDA Provides Update on Agency Response to Monkeypox Outbreak. PR Newswire. Published July 29, 2022. https://www.prnewswire.com/news-releases/fda-provides-update-on-agency-response-to-monkeypox-outbreak-301596348.htmlGoogle Scholar
Di Giulio, DB, Eckburg, PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004;4(1):1525. doi:10.1016/s1473-3099(03)00856-9Google ScholarPubMed
HAN Archive - 00468 | Health Alert Network (HAN). https://archive.cdc.gov/www_cdc_gov/han/2022/han00468.htmlGoogle Scholar
Brannen, DE, Alhammad, A, Branum, M, et al. International air travel to Ohio, USA, and the impact on malaria, influenza, and hepatitis A. Scientifica. 2016;2016:1-9. doi:10.1155/2016/8258946CrossRefGoogle Scholar
O’Toole, Á, Neher, RA, Ndodo, N, et al. Putative APOBEC3 deaminase editing in MPXV as evidence for sustained human transmission since at least 2016. bioRxiv (Cold Spring Harbor Laboratory). Published online January 24, 2023. doi:10.1101/2023.01.23.525187CrossRefGoogle Scholar
Zardi, EM, Chello, C. Human Monkeypox—a global public health emergency. Int J Environ Res Public Health. 2022;19(24):16781. doi:10.3390/ijerph192416781Google ScholarPubMed
Chakraborty, S, Mohapatra, RK, Chandran, D, et al. Monkeypox vaccines and vaccination strategies: current knowledge and advances. An update – correspondence. Int J Surg. 2022;105:106869. doi:10.1016/j.ijsu.2022.106869CrossRefGoogle ScholarPubMed
Nyame, J, Punniyakotti, S, Khera, K, et al. Challenges in the treatment and prevention of monkeypox infection; a comprehensive review. Acta Tropica. 2023;245:106960. doi:10.1016/j.actatropica.2023.106960Google ScholarPubMed
Nguyen, PY, Ajisegiri, WS, Costantino, V, et al. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017–2020. Emerg Infect Dis 2021;27(4). doi:10.3201/eid2704.203569Google ScholarPubMed